Bio-Labs Presents Most Effective, FDA Approved Combo for Covid-19 “Bioxovid” – (Nirmatrelvir + Ritonavir)

After the landmark success of (Remdesivir),(Favipiravir) & (Molnupiravir) in our fight against covid-19,Bio-Labs once again proves its solid stance by the launch of FDA approved oral treatment to effectively lower the Viral load of SARS-Cov-2 and other associated symptoms.

Bio-Labs launched the most effective combination of Nirmatrelvir and Ritonavir (Bioxovid) for fight against the Omicron and other variants of COVID-19.

The combination of Nirmatrelvir and Ritonavir is FDA approved for COVID-19 variants.

Ambassador of Azerbaijan H.E. Khazar Farhadov visits the manufacturing plant of Bio-Labs

It was an honour to host H.E Ambassador of Azerbaijan, Mr. Khazar Farhadov during a delegation visit to the manufacturing facility of Bio-Labs in Islamabad. The delegates were introduced to the processes of manufacturing and quality control excellence in place at the plant and the Ambassador appreciated the robust export presence globally of our products particularly in the CIS region. Ambassador Farhadov encouraged Bio-Labs to move forward with a mutual resolve to work on joint projects for pharmaceuticals development and expansion in Azerbaijan.

Date: 18-Jan-2022

Bio-Labs Has Successfully Launched another Prime Life-Saving Drug: Merobio (Meropenem)

Reliving the commitment and mission, Bio-Labs added a new product to its inventory. Bio-Labs is both gratified and proud to launch Merobio (Meropenem) recently with one and only aim that is VALUING LIFE.

Merobio (Meropenem) is not only a lifesaving drug but is only one of a few antibiotics that are putting up a sturdy fight against superbugs. From Elderly patients to Infants to Females with complicated infections Merobio (Meropenem) is the answer of this era.

Merobio Launch event was made special by the presence of the whole Bio-Labs’ team, senior doctors, Mentors, Motivational speakers, Life coaches and nutritional experts.

MOLNUCAP Capsules (Molnupiravir) breakthrough new drug for COVID-19

Bio-Labs is proud to be the first pharmaceutical company in Pakistan to launch the breakthrough new drug for COVID, Molnupiravir capsules, under the brand name of MOLNUCAP for export markets. After RIVONA injection (Remdesivir) and FAVILAB tablets (Favipiravir) successful launches, this is another feather in the cap of Bio-Labs for bringing the newest medicines to combat the COVID pandemic for patients globally.